New software patch for HyStar 3.2 available for download

A new software patch for HyStar 3.2.37 is available for download in our Downloads & Patches-section.

Bruker Daltonics and HealthLinx Expand Biomarker Discovery Collaboration

MELBOURNE, Australia--(BUSINESS WIRE)--Nov. 20, 2006--

HealthLinx Limited (ASX:HTX) today announced the signing of a joint patent agreement with Bruker Daltonics Inc. to further develop biomarkers that have been discovered under an existing collaboration between the two life science companies. These biomarkers are candidates for a number of pregnancy complications based on scientific research using Bruker Daltonics' ClinProt(TM) platform. Associate (...)

Bruker Daltonics Launches New CLINPROT™ Magnetic Beads for Glycoprotein Enrichment

LONG BEACH, Calif.--(BUSINESS WIRE)—October 28, 2006 --

At the HUPO World Congress 2006, Bruker Daltonics today launches its new ClinProt™ MB-LAC LCA (Lectin Affinity Chromatography - Lens Culinaris Agglutinin) glycoprotein kit. This ready-to-use glyco-kit further enhances Bruker Daltonics’ separation technology in the field of glycoprotein analysis and clinical proteomics research. The new LCA magnetic beads complement Bruker Daltonics’ (...)

Bruker BioSciences Reports Significantly Improved Earnings and Strong Revenue Growth for the Third Quarter of 2006

BILLERICA, Mass.--(BUSINESS WIRE)--Nov. 2, 2006--

Bruker BioSciences Corporation (NASDAQ: BRKR) today reported third quarter 2006 financial results.

On July 1, 2006, Bruker BioSciences completed its acquisition of Bruker Optics Inc., which was accounted for as a pooling of interests. As a result of this required GAAP accounting treatment, all historical financials have been pooled as if the companies had always been combined. The GAAP results of prior (...)

Bruker BioSciences Corporation to Release Third Quarter 2006 Financial Results on November 2nd, 2006

BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 26, 2006--

Bruker BioSciences Corporation (NASDAQ:BRKR) plans to release its third quarter financial results on Thursday, November 2nd, 2006 before the market opens. Bruker BioSciences will then host an operator-assisted earnings conference call that morning at 9 a.m. Eastern Time, 8 a.m. Central Time. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on the live web broadcast (...)

Bruker Daltonics and Isis Pharmaceuticals Announce the European Introduction of the Ibis T5000 Biosensor System

Ibis T5000 Uses PCR and ESI-TOF Mass Spectrometry for Microorganism Analysis

LONDON, United Kingdom – September 25, 2006 – At the 9th International Conference in Genomics and Proteomics of Human Pathogens in London, UK, Bruker Daltonics Inc. and Isis Pharmaceuticals, Inc. today announced the European introduction of the Ibis T5000™ biosensor system for the identification and characterization of microorganisms. The Ibis T5000 system is an automated (...)

Bruker BioSciences to Present at UBS Global Life Sciences Conference; Live Webcast on September 25th at 1:30 PM Eastern Time from New York

BILLERICA, Mass.--(BUSINESS WIRE)--Sept. 21, 2006--

Bruker BioSciences Corporation today announces that it will again join other leading healthcare and life sciences companies in presenting at the UBS Global Life Sciences Conference taking place September 25th through 28th in New York. Bruker BioSciences President and CEO Frank Laukien will present an overview of the Company, including an update on its three acquisitions since June, the new generation (...)